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The in vitro effects of the recreational drugs, ethanol (EtOH) and nicotine, on natural 
killer (NK) antibody-dependent cellular cytotoxic (ADCC) and lymphokine-activated 
killer (LAK) cell activities on normal lymphocytes were investigated. Lymphocytes 
precultured with EtOH at concentrations of 0.4 and 0.6% (v/v) produced significant 
suppression of NK and ADCC activities. In target-binding assays, EtOH decreased the 
target-binding capacity of effector cells. EtOH also inhibited the activities of Percoll- 
separated, NK-enriched large granular lymphocytes. EtOH-induced inhibition of NK 
activity could be reversed by incubating lymphocytes for 1 hr with interferon. The 
generation and lytic capacity of LAK cells was also significantly depressed by EtOH 
when added at the initiation of culture. Nicotine at concentrations of 5 and 10 t&ml, 
when added directly to mixtures of effector and target cells, produced significant inhi- 
bition of NK activity. Nicotine (2 p.g/ml) and EtOH (0.01 , 0.1, and 0.2%) at noninhibitory 
concentrations when added separately, showed significant suppression of NK activity 
when used in combination. Pretreatment of target cells with either EtOH or nicotine for 
4 hr did not affect cytotoxic activity. Inhibition of cytotoxicity was also not due to direct 
toxicity of effector cells because lymphocytes treated with either EtOH or nicotine 
showed normal “Cr release and their viability was comparable to that of untreated 
control cells. These studies demonstrate that EtOH and nicotine have significant immu- 
nomodulatory effects on the cytotoxic activities of human lymphocytes which may be of 
clinical relevance. 0 1990 Academic press, Inc. 
INTRODUCTION 
High intake of recreational drugs such as alcohol and nicotine, the latter 
through cigarette smoking, is associated with increased infections and malignan- 
cies (l-5). Smokers have a higher risk of a variety of cancers such as carcinoma 
of the lungs, esophagus, and bladder (6) and excessive alcohol consumption may 
predispose the individual to head and neck cancer and HIV infection (7, 8). 
Previous studies suggested a general decrease in various immune functions in 
alcoholics and heavy smokers (5, 9-15). 
Natural killer (NK) cells and lymphokine-activated killer (LAK) cell activities 
are believed to be early immune surveillance responses against nascent tumors 
and viral infections (16, 18). It was previously demonstrated that the NK activities 
of lymphocytes from alcoholics could be either decreased (9) or increased (19) 
compared to controls. These differences in activities may have been confounded 
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by several cofactors, including smoking, malnutrition, or cirrhosis. However, 
very little is known about the effects of alcohol or nicotine on the cytotoxic 
activities of normal lymphocytes. The present investigation examines the direct, 
in vitro effects of alcohol and nicotine on NK, ADCC, and LAK cell activities of 
normal lymphocytes. 
MATERIALS AND METHODS 
Experimental Design 
L-( -) Nicotine (Eastman Kodak Co., Rochester, NY) was diluted in Hanks’ 
balanced salt solution (HBSS) to give final concentrations ranging from 0.1 to 10 
kg/ml. Ethyl alcohol USP, absolute 200 proof (AAPER Alcohol and Chemical 
Co., Kentucky) was diluted in HBSS to give final concentrations ranging from 
0.01 to 0.6% (v/v). Drugs were added either directly to the reaction mixture 
containing effector and target cells or incubated with effector cells for 24 to 72 hr, 
washed, and tested for NK, ADCC, or target-binding functions. Controls con- 
taining target and effector cells without added drugs, or targets or effector cells 
plus drugs were examined concomitantly. In experiments to investigate the syn- 
ergistic effect of drugs, alcohol and nicotine were added together to cultures 
which were examined for cytotoxic activities. 
Separation of Lymphocytes 
Mononuclear cells were isolated from heparinized (20 U/ml) venous blood ob- 
tained from healthy nonsmoking adults who had abstained from alcohol consump- 
tion for at least 1 week and who otherwise were moderate to low drinkers. Lym- 
phocytes were separated by a modified method of Boyum (20). Donors were 
apprised of the study and consents were obtained consistent with the policies of 
The University of Michigan and the National Institutes of Health. Blood was 
diluted with an equal volume of normal saline and was centrifuged at 400g for 30 
min at 18°C. The mononuclear cell band was harvested, washed three times with 
saline, and resuspended in RPM1 1640 medium containing 25 mM Hepes buffer 
supplemented with 5% heat-inactivated fetal calf serum (FCS) (GIBCO, Grand 
Island, NY), 80 t&ml gentamicin (Shering Corp., Kenilworth, NJ), and 300 kg 
fresh glutamine/ml (complete medium). 
Mononuclear cells were depleted of adherent cells by passage over a column of 
Sephadex G-10 beads (Pharmacia Fine Chemicals, Piscataway, NJ), equilibrated 
in the same medium. After 45 min of incubation at 37°C nonadherent peripheral 
blood lymphocytes (PBL) were washed out with one bed volume of medium at 
37°C. The cell recovery was -70% of the total input, and macrophage contami- 
nation as indicated by nonspecific esterase staining was less than 2%. 
Percoll Fractionation of Lymphocytes 
Enrichment of NK effector cells using a discontinuous density gradient of 
Percoll (Pharmacia) was carried out as described (21). To prepare a discontinuous 
gradient, Percoll solution was mixed at various concentrations with RPM1 1640 
medium, and 2-ml aliquots were gently layered into 15 x 130-mm round-bottomed 
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glass tubes. PBL were layered on top of the gradient and were centrifuged at 300g 
for 45 min at 20°C. Six fractions, with the uppermost 37.5% Percoll and the lower 
50.0% Percoll, were collected from the top with a Pasteur pipet and washed twice 
in RPM1 1640 medium. The least dense fraction banding at the 37.5% interface 
consistently showed the highest NK activity and was used as a source of NK- 
enriched cells. Recovery of cells was -85% of the input, and viability always 
exceeded 95% by trypan blue dye exclusion. 
Incubation of Lymphocytes with Drugs 
PBL depleted of adherent cells or NK-enriched cells isolated on a Percoll 
gradient were suspended in complete medium in 5 x 70-mm tissue culture tubes 
at a concentration of 1 x lo6 cells/ml to which either EtOH or nicotine was added 
and incubated for 24, 48, and 72 hr in a humidified environment of 5% CO, in air 
at 37°C. A duplicate set of cultures without added drugs was included as controls. 
Cell viability was comparable with control cultures as determined by trypan blue 
dye exclusion and was not affected by nicotine concentrations of 0.1 to 10 &ml 
or EtOH at 0.01 to 0.6% (v/v). Treated and control cultures were assayed for their 
target-binding activity and ability to mediate NK and ADCC functions. Evapora- 
tion of EtOH from our cultures was approximately 39% after the first 24 hr, 48% 
after 48 hr, and 59% by the end of 72 hr of culture as determined by gas chroma- 
tography . 
Tumor Target Cells 
The human erythroleukemia cell line, K562; the histiocytic lymphoma cell line, 
U937; the T leukemia cell line, HSB; and the B cell leukemia line, SB; were used 
as targets in cytotoxicity tests. K562, U937, and HSB are NK-sensitive targets 
while SB is an NK-resistant cell line when used in a 4-hr “Cr release assay. All 
target cells were maintained in complete medium. Target cells were passaged for 
48 hr and washed twice with complete medium. To 0.8-ml aliquots of complete 
medium containing 5 x lo6 tumor cells, 200 &I of 51Cr as sodium chromate (New 
England Nuclear, Boston, MA) was added as described (18, 22). The cells were 
incubated at 37°C for 1 hr in a humidified atmosphere of 5% CO,, in air with 
intermittent shaking. Following incubation, the cells were washed three times 
with complete medium and resuspended to a concentration of 1 x lo6 cells/ml. 
Assay for NK Activity 
NK activity was determined in a direct ‘lCr-release assay as described previ- 
ously (18, 22, 23). Briefly, varying concentrations of viable effector cells in com- 
plete medium were added to triplicate cultures of 51Cr-labeled target cells in 0.2 ml 
volumes in V-bottom microtitration plates (Dynatech Labs, Alexandria, VA). 
After centrifugation at 40g for 2 min, the cells were incubated at 37°C in a hu- 
midified atmosphere of 5% COz in air for 4 hr. Percentage cytotoxicity was cal- 
culated as 
% Cytotoxicity = 
experimental release - spontaneous release 
total release - spontaneous release 
x 100, 
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where total release represents counts obtained in an aliquot of 2 x 104 target cells, 
and spontaneous release represents counts obtained from control wells containing 
only 2 x lo4 target cells. The spontaneous release from target cells for all cyto- 
toxicity assays was always less than 5% of total labeling. Cytotoxicity was also 
expressed as lytic units (LU)/lO’ effector cells, defined as the number of effector 
cells needed to yield 30% cytotoxicity of 1 x lo4 target cells. LU were calculated 
from the cytotoxicity curve by using four different effector to target (E:T) cell 
ratios for each test by linear regression analysis. 
Assay for ADCC 
ADCC activity was determined as described earlier (18, 22). Briefly, 50 p,l of 
varying concentrations of effector cells was added to 50 t.~l of complete medium 
containing ‘lCr-labeled SB target cells and 100 ~1 of a 2 x low4 dilution of rabbit 
anti-SB antisera previously found to yield maximal ADCC. Percentage ADCC 
activity was calculated as described above for NK activity, with the following 
exceptions. Spontaneous release represents counts released in control wells con- 
taining effector cells, labeled SB target cells, and media instead of anti-SB anti- 
bodies, and total release represents counts obtained in an aliquot of 1 x lo4 
“Cr-labeled SB target cells. Percentage inhibition of NK and ADCC activities was 
calculated as 
% cytotoxicity of % cytotoxicity of 
% Inhibition = 
control lymphocytes - treated lymphocytes 
% cytotoxicity of control lymphocytes 
x 100. 
Target-Binding Assay 
The target-binding cell assay was used as described by Haliotis et al. (24). 
Lymphocytes were precultured with varying concentrations for EtOH for 72 hr, 
washed twice, mixed with a fivefold excess of K562 target cells, centrifuged at 
15Og for 5 min, and incubated at 37°C for 5 min. After incubation, lymphocyte- 
target mixtures were transferred to ice, the pellets were gently resuspended, and 
the number of lymphocytes binding to tumor targets was determined microscop- 
ically with a hemocytometer. 
Generation of LAK Cells 
Commercially available recombinant IL2 (Collaborative Research, Inc., Bed- 
ford, MA) was diluted in complete medium and stored at - 70°C before use. IL2 
concentrations of 5 to 10 U/ml in complete medium (LAK medium) were used to 
generate LAK cells. PBL were activated to generate LAK cells by in vitro incu- 
bation for 5 to 6 days in medium containing EtOH at concentrations of 0.1, 0.2, 
0.4, and 0.6% (v/v) in upright 24-cm2 flasks at a density of 1 x lo6 cells/ml at 37°C 
in a 5% C02/95% air atmosphere as described (25). 
Assay for LAK Cell Activity 
The LAK cell assay was performed as described for the NK assay using a 4-hr 
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51Cr release technique (18, 22, 23). A fixed number of viable effector cells in 
complete medium was added to triplicate cultures of “Cr-labeled targets in V- 
bottom microtitration plates (Costar, Cambridge, MA). After centrifugation at 
40g for 2 min, they were incubated at 37°C in a humidified atmosphere of 5% CO2 
in air for 4 hr. At the end of incubation, the plates were centrifuged at 400g for 10 
min and lOO-~1 aliquots were removed from each well, transferred to glass tubes, 
and read in a gamma counter. Percentage cytotoxicity was calculated as described 
for NK cells. 
Statistical Analysis 
The statistical significance of differences in mean values was determined by a 
single tail Student’s t test. 
RESULTS 
Effect of EtOH on NK and ALXC Activities 
In view of the finding that alcoholics are more susceptible to various infections 
and malignancies (1-5) and since a potential relationship exists between AIDS and 
alcohol abuse (7, 8), we examined the direct effect of alcohol on the NK and 
ADCC activities of normal lymphocytes. Figure 1 shows the effect of EtOH on 
NK cell activities of lymphocytes precultured in alcohol-containing medium. 
EtOH at a final concentration of 0.1% produced a slight increase in NK activities 
(40% cytotoxicity vs 36% cytotoxicity) against K562 target cells compared to 
untreated control cultures. EtOH at a 0.2% final concentration demonstrated a 
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FIG. 1. Effect of EtOH on NK Activity. 1 X lo6 PBL/ml was precultured with media contaiuing 
varying concentrations of EtOH for 72 hr at 37’C in a 5% CO, in air atmosphere. PBL were washed 
and tested for their cytotoxicity against different target cells at a 10: 1 E:T cell ratio. The percentage 
cytotoxicity was calculated as under Materials and Methods. Values are the mean -+ SD of triplicate 
determinations from four separate experiments. 
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cultures (36% cytotoxicity). Lymphocytes precultured with EtOH at higher con- 
centrations of 0.4 and 0.6% produced significantly decreased levels of NK activity 
(13.4% cytotoxicity, P < 0.025 and 9.% cytotoxicity, P < 0.025, respectively). 
PBL precultured with EtOH at 0.1 and 0.2% concentrations produced slight in- 
creases in NK activity (42 and 44%, respectively) against HSB target cells com- 
pared to 37% cytotoxicity shown by control cultures. EtOH at 0.4 and 0.6% final 
concentrations, respectively, demonstrated 17.5% (P < 0.05) and 17.0% (P < 
0.025) cytotoxicity compared to 37% cytotoxicity produced by control cultures. 
PBL precultured in media containing 0.6% EtOH manifested a lower level of 
cytotoxicity (11.5%, P < 0.05) against U937 target cells compared to 18.0% cy- 
totoxicity produced by control cultures. EtOH at lower concentrations of 0.1,0.2, 
and 0.4% did not produce significant inhibition of NK activity. Table 1 demon- 
strates the kinetics of inhibition of NK activity against K562 target cells by EtOH. 
PBL cultured with EtOH demonstrated a progressive suppression of NK activity. 
Suppression was noticeable at 24 hr (84 LU, P = NS) and 48 hr (72 LU, P = NS) 
and reached a peak at 72 hr (53 LU, P < 0.05) compared to 98 and 84 LU produced 
by control and EtOH-treated cultures at 0 hr. Figure 2 presents data on the effect 
of EtOH on the ADCC activities of lymphocytes against antibody-coated SB 
target cells. PBL precultured with increasing concentrations of EtOH (0.1, 0.2, 
0.4, and 0.6%) produced dose-dependent inhibition of ADCC activities; inhibition 
was most significant at 0.4% (11% cytotoxicity, P < 0.05) and 0.6% (lo%, P < 
0.05) EtOH concentrations compared to 18% cytotoxicity produced by control 
cultures. 
Inhibition of the NK and ADCC activities of PBL precultured with EtOH at 
different E:T cell ratios is demonstrated in Table 2. Cytotoxicity was dependent 
upon the number of effector cells used and the inhibitory effect of EtOH was 
observed at several E:T cell ratios. To determine whether EtOH affects the target- 
binding capacity of the effector cells, an early event in the lytic process, target- 
binding assays were performed (Table 3). EtOH significantly reduced target bind- 
ing in a dose-dependent manner. 
Data presented in Table 4 demonstrate the effect of EtOH on the NK activity 
of PBL in comparison with that of LGL. PBL precultured with 0.1% EtOH 
TABLE 1 
KINETICS OF INHIBITION OF NK ACTIVITY BY EtOH” 
Treatment of 
lymphocyte culture 0 




Cytotoxicity (lytic units) 
None 98.2 k 8.6b 88.0 * 10.3 87.5 2 11.2 82.6 2 13.0 
(NW (NS) (NW (P < 0.05) 
0.6% EtOH 84.6 k 11.2 72.4 f  8.3 68.7 2 6.8 53.1 + 7.8 
0 1 x lo6 PBL/ml was precultured with EtOH at 0.6% final concentration for 0 to 72 hr and tested 
for NK activity against KS62 at a 1O:l E:T cell ratio. 
b Results are the mean k SD of triplicate determinations of four separate experiments. 
’ Statistically not significant. 
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FIG. 2. Effect of EtOH on ADCC Activity. I X 10’ PBL/ml was precultured with different con- 
centrations of EtOH for 72 hr. washed, and tested against antibody-coated SB target cells at a 25: 1 E:T 
cell ratio. Values are the mean 2 SDM of four separate experiments performed in triplicate. 
demonstrated cytotoxicity comparable with that of control cultures. EtOH at 0.4 
and 0.6% concentrations demonstrated significantly lower cytotoxicities of 12 and 
10% compared to 19% cytotoxicity manifested by control cultures. Autologous 
LGL precultured in media demonstrated a significantly increased Ievei of cyto- 
toxicity (43.5%) compared to PBL (19%). LGL precultured with higher concen- 
TABLE 2 
EFFECT OF EtOH ON NK AND ADCC ACTIVITIES OF LYMPHOCYTES AT DIFFERENT E:T 
CELL RATIOS” 
~~~~ _.._ ~~~- -~~.-~~~ -. 
Source of 
E:T cell ratios 
effector cells so:1 25: 1 lO:l 
% Cytotoxicity 
Control 41.5 t 4.2’ 35.6 + 4.0 22.7 2 3.4 
NK Activity“ 
0.6% EtOH (P < 0.1) (P < 0.01) tP *< 0.05) 
treated 25.9 2 2.8 (37.6)’ 19.2 2 3.0 (46.0) 11.6 t 3.1 (54.8) 
Control 29.6 ” 3.8 27.7 k 4.1 10.6 t 1.8 
ADCC Activity’ 
0.6% EtOH (P < 0.05) (P < 0.01) If  c 0.05) 
treated 19.4 +- 2.7 (34.4) 14.0 2 2.3 (49.4) 4.6 i 1.9 (56.6) 
’ 1 x lo6 PBL/ml was precultured with EtOH at 0.6% final concentration for 72 hr. washed, and 
tested for their NK activity. 
b Results are the mean ? SD of triplicate determinations of four separate experiments. 
’ Numbers in parentheses are percentage suppression of cytotoxicity. 
d The U937 histiocytic lymphoma cell line was used as targets in NK assay. 
e The antibody-coated human B cell line, SB, was used as targets in ADCC assay. 
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TABLE 3 
EFFECT OF EtOH ON BINDING OF TARGET CELLS BY NK EFFECTOR LYMPHOCYTES” 
EtOH 
concentration 
(%v/v) Target-binding cells 
% Inhibition of 
target-binding cells 
0 20.8 + 2.4 - 
0.1 22.5 k 4.2 -8.1b 
0.2 18.8 k 3.0 9.6 
0.4 13.0 f  1.5 37.5 (P < 0.05) 
0.6 11.0 r 1.1 47.1 (P < 0.025) 
D PBL precultured with different concentrations of EtOH for 72 hr, washed, and mixed with K562 
target cells. Lymphocytes bearing at least one surface-bound target cell were counted in a hemocy- 
tometer. The results are expressed as the mean k SD of two experiments. 
b Minus sign indicates enhancement. 
trations of EtOH (0.4 and 0.6%) also showed significantly increased inhibition of 
NK activity, with cytotoxicities of 23 and 21%, respectively. 
Effect of Nicotine on NK Activity 
In view of the finding that cigarette smoking is associated with a number of 
immune abnormalities, including reduction in NK activities (3, 5, 11, 27, 28), we 
studied the in vitro effects of nicotine on NK functions. Data in Table 5 demon- 
strate that nicotine, when added directly at concentrations of 5 and 10 CLgfml, 
significantly inhibited NK activity which was more pronounced at lower E:T cell 
ratios. On the basis of reports that lymphocytes from alcoholics and smokers 
demonstrate lower NK activity (3, 9) we also examined the combined effects of 
alcohol and nicotine at noninhibitory concentrations, when used separately, on 
the NK activity of PBL. The results presented in Fig. 3 show that EtOH alone at 
0.01, 0.1, and 0.2% concentrations produced slight enhancement of the NK ac- 
tivity of PBL (2, 17, and 8% cytotoxicity, respectively). Nicotine alone at 0.1 
)&ml, the lowest concentration, produced a slight enhancement (15%) of NK 
activity, while at 1 and 2 t.&ml it caused negligible inhibition (2 and 8% inhibition, 
TABLE 4 





0 19.8 2 3.6 43.5 2 8.6 
EtOH 0.1% 20.9 f  3.9 46.1 2 5.8 
EtOH 0.4% 12.2 2 3.1 (P < 0.05) 23.5 2 5.1 (P < 0.05) 
EtOH 0.6% 10.3 2 3.2 (P < 0.05) 21.7 2 7.8 (P < 0.05) 
0 Lymphocytes were precultured with different concentrations of EtOH for 72 hr, washed, and 
tested for NK activity against K562 target cells at a 5:1 E:T ratio. LGLs were prepared on a discon- 
tinuous density gradient of Percoll as described (41). The fraction of lymphocytes banding at the 37.5% 
Percoll interface was used as LGL. Seventy-five to 80% of the cells of this fraction were positive to 
staining with the HNKI monoclonal antibody. Values are the mean f  SD of four separate experiments 
performed in triplicate. 
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TABLE 5 
EFFECT OF NICOTINE ON NK ACTIVITY OF LYMPHOCYTES~ 
___- 
Nicotine Effector:target cells 
concentration 
olg/ml) 50: 1 25:l IO:1 
Media control 59.5 2 &lb 54.7 -t 6.0 32.2 * 3.1 
1 65.1 f  7.8 (NS) 52.5 -+ 8.7 (NS) 29.9 2 4.3 (NS) 
2 60.9 k 5.6 (NS) 48.6 k 4.1 (NS) 30.2 2 3.9 (NS) 
5 46.9 2 4.3 (P < 0.1) 36.7 2 7.4 (P < 0.05) 20.4 a 3.4 (P < 0.05) 
10 31.9 2 4.5 (P < 0.01) 25.3 f  3.1 (P < 0.0025) 14.8 * 2.8 (P < 0.005) 
0 Nicotine was added directly to the mixture of effector and U937 target cells in a 4-hr “Cr release 
assay. 
’ Values represent mean 2 SD of four separate experiments performed in triplicate. 
c Statistically nonsignificant. 
respectively) of NK activity. In mixing experiments, PBL precultured with 2 pg 
nicotine/ml plus varying concentrations of EtOH (0.01, 0.1, and 0.2%) produced 
dose-dependent depression of the NK activity of PBL, with inhibitions of 22 (P < 
0.05), 3 1 (P < 0.05), and 43% (P < 0.025), respectively, at 0.01, 0.1, and 0.2% 
EtOH concentrations. This suggests that EtOH and nicotine individually at non- 
inhibitory concentrations produce significant suppression of NK activity when 
added in combination. 
Eflect of EtOH on LAK Cell Generation 
Experiments were undertaken to investigate whether EtOH directly affects the 
activity of LAK cells or prevents their generation. Our results demonstrate that 
direct addition of EtOH at concentrations of 0.1, 0.2, 0.4, and 0.6% to a mixture 
50 - 
- A = Nicotine (2pg/ml)+EtOH (0.01%) Z
40 - B = Nicotine (2pg/ml)+EtOH (0.1%) 
I= 
2 30 








- I  I  I  I  1 1 I  1 1 , - -T - t  
0.01 0.1 0.2 0.1 1 .o 2.0 A B C 
EtOH (%) Nicotine (pg/ml) Nicotine+EtOH 
FIG. 3. Synergistic Effect of EtOH and Nicotine on NK Activity. 1 X lo6 PBL/ml was cultured with 
EtOH, nicotine, or EtOH + nicotine for 72 hr, washed, and tested for cytotoxicity against U937 target 
cells at a 25: 1 E:T cell ratio. Inhibition of NK activity was calculated on the basis of the cytotoxicity 
produced by control cultures. Values represent the mean 2 SD of three separate experiments per- 
formed in triplicate. 
404 NAIR, KRONFOL, AND SCHWARTZ 
of effector and target cells did not affect the lytic capacity of LAK cells in a 4-hr 
assay period (data not presented). Table 6 shows the cytotoxic activity of LAK 
cells generated in the presence of different concentrations of EtOH against NK- 
nonsensitive (SB) and NK-sensitive (HSB) targets. EtOH at 0.4 and 0.6% con- 
centrations significantly inhibited LAK cell induction, yielding cytotoxicities of 
128 (P < 0.025) and 87 LU (P < 0.025), respectively, compared to 152 LU pro- 
duced by control cultures against HSB targets and 18 and 17 LU compared to 35 
LU manifested by control cultures against SB target cells. 
Effect of Interferon on Suppression of NK Activity by EtOH 
We examined the role of interferon, an agent known to enhance NK activity, on 
the suppression of NK activity by EtOH (Table 7). Lymphocytes precultured in 
media alone and then treated with 500 U/ml of recombinant interferon-a for 1 hr 
demonstrated enhancement of their NK activity (46%) compared to the NK ac- 
tivity of lymphocytes cultured in media alone. Lymphocytes precultured with 
0.4% EtOH demonstrated 22% cytotoxicity resulting in 30% suppression and this 
suppression was significantly reversed to only 4% by treatment with interferon for 
1 hr. EtOH at a 0.6% concentration produced 41% suppression of NK activity 
which was reversed to 7% suppression by interferon treatment for 1 hr. 
DISCUSSION 
Earlier studies showed that chronic alcohol consumption was associated with 
humoral (29-31) and cellular (4, 32, 33) immunologic abnormalities, including 
effects on suppressor (33-36), helper (37), and cytotoxic cell activities (2, 9, 38, 
39). Cigarette smoking has also been shown to have a number of effects on the 
immune response of human lymphocytes such as Ig production (11,27), alteration 
in the T4/T8 lymphocyte ratio (11, 27), reduced NK activity (3), and depressed 
mitogen-induced lymphocyte transformation (15). Miller et al. (11) showed sig- 
nificant alterations in immunoregulatory T cells, such as decreased levels of 
CD4+ and increased levels of CD8+ cells, in heavy smokers and these effects 
could be reversed upon cessation of smoking. Further, cigarette smoking has also 
TABLE 6 





Cytotoxicity (lytic units) 
0 152.8 2 12.4’ 35.7 -+ 6.1 
EtOH 0.1% 132.8 2 11.3 28.1 k 8.3 
EtOH 0.2% 135.9 f  9.1 31.7 f  9.4 
EtOH 0.4% 128.3 2 6.7 (P < 0.025) 18.3 + 6.7 (P < 0.05) 
EtOH 0.6% 87.6 ” 5.3 (P < 0.025) 17.9 * 6.8 (P < 0.025) 
a 1 x lo6 PBL/ml of media was precultured with recombinant IL2 (5 to 10 U/ml) with or without 
different concentrations of EtOH for 5 to 6 days, washed, and tested against NK-resistant SB targets 
and NK-sensitive HSB targets at 10: 1 E:T cell ratios. 
b Values represent the mean f  SD of three separate experiments performed in triplicate. 
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TABLE I 
EFFECT OF INTERFERON (IFN) ON INHIBITION OF NK ACTIVITY BY EtOH” 
____ 
Treatment of 
effector cells % Cytotoxicity % Suppression 
0 32.7 -t 4.9’ - 
IF (500 U)* 47.8 2 5.2 - 46. I” 
EtOH 0.4% 22.6 -c 5.0 30.x 
EtOH 0.4% + IF (500 U) 34.3 2 4.6 4.8 
EtOH 0.6% 19.2 t 3.9 41.2 
EtOH 0.6% + IF (500 U) 30.4 rt 4.8 7.0 
- 
0 Lymphocytes were cultured alone or with EtOH for 72 hr, washed, and further treated with IF for 
1 hr and tested for their NK activity against K562 target cells at a 50: 1 E:T cell ratio. 
b Human recombinant IFN-a was used at 500 U/ml. 
c Results are the mean cytotoxicity 2 SD of triplicate determinations of three separate experiments. 
d Data represent percentage suppression of cytotoxicity compared to control cultures. Minus sign 
indicates enhancement. 
been associated with increased levels of humoral mediators of stress such as 
catecholamines and corticosteroids (41). Previously we demonstrated that corti- 
costeroids inhibit the NK activity of human lymphocytes (42). Also, we have 
reported that patients with a history of intravenous drug abuse, often associated 
with excessive alcohol consumption, demonstrated decreased levels of NK, 
ADCC, lectin-dependent cellular cytotoxicity , and interferon and interleukin 2- 
induced NK activities (22). 
We report herein that recreational drugs such as alcohol and nicotine can sup- 
press NK, ADCC, and LAK cell activties of normal lymphocytes. However, this 
alcohol-induced suppression could be significantly reversed by IF. In the present 
investigation, suppression is operationally defined as the inhibition of effector 
cells after addition of drugs directly to the reaction mixture or after preculturing 
lymphocytes with drugs as indicated. The decrease in cytotoxicity observed was 
not due to toxic effecs of drugs on effector cells, as nicotine- and alcohol-treated 
cells showed levels of viability comparable to untreated control cultures. Also, 
lymphocytes precultured with drugs showed no increase in the spontaneous re- 
lease of “Cr compared to untreated lymphocytes (data not presented). Suppres- 
sion of cytotoxic activity is not likely due to effects of drugs on target cells since 
target cells treated with drugs for 4 hr were as sensitive to lysis by effector cells 
as untreated control target cells. Direct addition of alcohol to mixtures of effector 
and target cells did not produce any significant inhibition of NK, ADCC, or LAK 
cell activities of lymphocytes (data not presented). Alcohol-induced suppression 
was dose dependent and required 72 hr of preculture of lymphocytes with alcohol 
for maximum suppression (Table 1). NK activity showed a gradual decline over 24 
to 48 hr when lymphocytes were cultured with EtOH. Similar results were ob- 
tained in other experiments using higher E:T cell ratios, 50: 1 and 25: 1, and U937 
and HSB target cells (data not presented). Further, lymphocytes maintained de- 
creased levels of cytotoxicity even several hours after removing alcohol by wash- 
ing (data not presented). Alcohol at lower concentrations (0.1 to 0.2%) usually 
produced a slight but not significant enhancement of NK activity consistent with 
an earlier report (39), while alcohol at higher concentrations produced significant 
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inhibition. Others have shown that the cytotoxic functions of blood monocytes 
and Kupffer cells were increased by alcohol at 0.4% concentration (40). This 
contrasts with the inhibitory effect of alcohol at similar concentrations on the NK 
functions of lymphocytes as reported herein. The apparent contradiction may be 
due to differential effects of alcohol on cells from various tissue origins or lin- 
eages. The mechanisms by which NK activity is slightly stimulated by lower 
concentrations of alcohol (0.1%) are not well understood. It is possible that alco- 
hol at lower concentrations may have a beneficial action on effector-target con- 
jugation as demonstrated in Table 3, possibly resulting from changes in membrane 
fluidity and composition or receptor rearrangement on effector cells. Also, it is 
possible that lower concentrations of alcohol may positively affect the ability of 
cytolytic factors to mediate cytotoxicity by enhancing their release. However, 
these possibilities need further study. 
Although alcohol levels in tissues and cell membranes may vary, a concentra- 
tion of 0.3 to 0.4% in blood results in severe intoxication while 0.5% leads to 
coma. Chronic alcoholics may manifest greater suppressive effects of alcohol on 
cytotoxic activities because increased levels of alcohol are maintained over longer 
periods of chronic drinking. The results presented here demonstrate that alcohol 
at levels comparable with severe intoxication (0.4%) suppresses NK and ADCC 
activities. As evaporation of EtOH in our cultures reduced the concentration by 
59% after 72 hr, as quantitated by gas chromatography, the inhibitory effects of 
alcohol may occur at even lower levels than the starting concentration. 
Only limited information is available on the immunoregulatory mechanisms 
affecting LAK cell activities. Previous studies (43) suggest that LAK cells may be 
derived from phenotypically heterogenous precursors. We recently reported that 
the generation and lytic capacity of LAK cells were significantly affected by Con 
A and prednisolone (25), demonstrating that, like other cell functions, LAK cell 
cytotoxicity is also under active immunologic control. The current study presents 
evidence that alcohol significantly inhibits the generation and lytic capacity of 
LAK cells (Table 6). However, alcohol, when added directly to a mixture of fresh 
LAK and target cells, did not cause any significant effects. 
The level of nicotine in various body fluids may vary considerably. The plasma 
level of nicotine of moderate smokers (13.2 cigarettes/day) was estimated to be 
15.7 + 10.1 rig/ml (44) and in heavy smokers (3 packs/day) up to 60 rig/ml (Ovid 
Pomerleau, University of Michigan, personal communication). The urine and sa- 
liva nicotine levels in moderate smokers (13.2 cigarettes/day) were found to be 
1.84 and 0.476 ug/ml, respectively (44). A recent paper suggests that increments 
in blood nicotine concentrations after the smoking of a single cigarette ranges 
from 5 to 30 &ml depending upon how the cigarette is used (45). Earlier studies 
estimated that heavy smokers maintain nicotine concentrations up to 0.28 pg/ml 
in the blood (46). However, acute levels of nicotine in smokers with a long smok- 
ing history may be much higher than the reported chronic blood levels. Previous 
studies have shown lower serum Ig concentrations and decreased levels of CD4+ 
subsets in smokers (11,27). Neher (14) has shown that concentrations of nicotine 
up to 122 kg/ml produced decreased in vitro lymphocyte DNA synthesis in re- 
sponse to PHA stimulation without any toxicity, suggesting that cigarette smoking 
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may affect cellular immunity. The nicotine concentrations used in the present 
study exceed levels reportedly attained in viva by smokers. The present studies 
are our preliminary attempts to develop an in vitro model to examine the immu- 
nomodulatory effects of nicotine on human lymphocyte functions. However, 
these concentrations were not grossly toxic to lymphocytes as the viability of cells 
precultured with nicotine was similar to that of control cultures. Nicotine and 
alcohol at concentrations which did not affect NK activity when added alone 
produced a significant synergistic inhibitory effect on NK functions when added 
in combination. It is possible that this synergistic effect may be mediated through 
different mechanisms such as down-regulation of IL2 production, alteration of 
IL2 and NK receptors, and/or release of potential suppressive factors. This ob- 
servation may have implications in vivo and may explain the reduced immuno- 
logical responses often manifested by patients who are both alcoholics and 
smokers. 
Interferon seems to play a major role in immunoregulation, including augmen- 
tation of NK activity in vitro and in vivo (47, 48). The current study demonstrates 
that EtOH-induced suppression of NK activity could be reversed with interferon, 
Several mechanisms for this effect are possible: Interferon may enhance target 
binding, activate pre-NK cells or precursor cells which are alcohol resistant, 
and/or activate mature NK cells rendered transiently inactive due to alcohol treat- 
ment. Elucidation of the mechanism(s) underlying the reversal of EtOH-induced 
immunosuppression by interferon awaits further investigation. 
Similarly, the mechanisms by which alcohol or nicotine suppress cytotoxic 
functions are not fully understood. It is possible that these mechanisms may vary 
from target-binding to postbinding stages of the lytic process, including the pro- 
duction of soluble cytotoxic factor. Our studies demonstrate that alcohol signifi- 
cantly reduces the number of target-binding lymphocytes, suggesting that one 
mechanism may be directed at the early events of target lysis. It is possible that 
alcohol and nicotine may even have a stimulatory effect on suppressor cell sub- 
populations which regulate both NK and LAK cell functions. However, the ef- 
fects of EtOH on postconjugate stages such as recycling ability or natural killer 
cytotoxic factor production by effector cells also remain to be studied. 
Although the mechanisms of the immunomodulatory effects of alcohol and 
nicotine are not clearly understood, our present studies may provide an explana- 
tion for the proposed link between alcohol and nicotine and increased incidence of 
infections and malignancies. Smoking and alcohol consumption, an unfortunate 
common combination, are frequently associated with other risk factors for HIV 
infections. Thus the synergistic suppressive effects of nicotine and alcohol on 
immune responses may play a role in increasing susceptibility to AIDS. 
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